Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, Spero Therapeutics (SPRO) has a market cap of $42.160 million USD. According to our data, Spero Therapeutics is ranked No.8186 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $42.16 M |
-24.92%
|
| Dec 31, 2024 | $56.15 M |
-29.93%
|
| Dec 29, 2023 | $80.14 M |
-15.03%
|
| Dec 30, 2022 | $94.32 M |
-89.19%
|
| Dec 31, 2021 | $0.87 B |
-17.43%
|
| Dec 31, 2020 | $1.06 B |
101.66%
|
| Dec 31, 2019 | $0.52 B |
56.34%
|
| Dec 31, 2018 | $0.34 B |
-47.66%
|
| Dec 29, 2017 | $0.64 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
USA
|
 GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
UK
|
 AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
UK
|
 Novartis
NVS
|
$219.89 B |
0.932 B
|
Switzerland
|
 Sanofi
SNY
|
$124.64 B |
0.327 B
|
France
|
 AbbVie
ABBV
|
$306.02 B |
0.008 M
|
USA
|
 Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
USA
|
 Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
USA
|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
| Market Cap | = | SPRO Stock Price | * | SPRO Shares Outstanding |
| = | $0.75 | * | 55.90 M | |
| = | $42.16 M |